Cited by 1,381Gene expression and cancer classificationBreast Cancer Treatment StudiesCancer Genomics and Diagnostics

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Pancancer survival analysis of cancer hallmark genes

Open access

Nagy, Ádám, Munkácsy, Gyöngyi, Győrffy, Balázs·2021·Scientific Reports

DOI 10.1038/s41598-021-84787-5PMC PMC7961001

Open this paper in CoChat — free account

Abstract

Cancer hallmark genes are responsible for the most essential phenotypic characteristics of malignant transformation and progression. In this study, our aim was to estimate the prognostic effect of the established cancer hallmark genes in multiple distinct cancer types. RNA-seq HTSeq counts and survival data from 26 different tumor types were acquired from the TCGA repository. DESeq was used for normalization. Correlations between gene expression and survival were computed using the Cox proportional hazards regression and by plotting Kaplan–Meier survival plots. The false discovery rate was calculated to correct for multiple hypothesis testing. Signatures based on genes involved in genome instability and invasion reached significance in most individual cancer types. Thyroid and glioblastoma were independent of hallmark genes (61 and 54 genes significant, respectively), while renal clear cell cancer and low grade gliomas harbored the most prognostic changes (403 and 419 genes significant, respectively). The eight genes with the highest significance included BRCA1 (genome instability, HR 4.26, p < 1E−16), RUNX1 (sustaining proliferative signaling, HR 2.96, p = 3.1E−10) and SERPINE1 (inducing angiogenesis, HR 3.36, p = 1.5E−12) in low grade glioma, CDK1 (cell death resistance, HR = 5.67, p = 2.1E−10) in kidney papillary carcinoma, E2F1 (tumor suppressor, HR 0.38, p = 2.4E−05) and EREG (enabling replicative immortality, HR 3.23, p = 2.1E−07) in cervical cancer, FBP1 (deregulation of cellular energetics, HR 0.45, p = 2.8E−07) in kidney renal clear cell carcinoma and MYC (invasion and metastasis, HR 1.81, p = 5.8E−05) in bladder cancer. We observed unexpected heterogeneity and tissue specificity when correlating cancer hallmark genes and survival. These results will help to prioritize future targeted therapy development in different types of solid tumors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41598-021-84787-5

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Overview of cutoff determination and survival distribution in the database. The determination of the best cutoff value in the survival analysis demonstrated with the CDK1 gene in kidney papillary carcinoma (A) and ovarian cancer (B). Survival time characteristics of tumors with observed events (C).CC BY · PubMed Central

Figure 2 The prognostic power of cancer hallmark genes.CC BY · PubMed Central

Figure 3 Effect of hallmark signatures (A) and tumor mutation burden (C) on patient survival. Summary of the significant prognostic hallmark signatures in different types of tumors (B).CC BY · PubMed Central

Figure 4 Best performing genes in at least 10 distinct tumor types.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,438
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Tamoxifen for early breast cancer: an overview of the randomised trials
Abe, O., Bartholomeus, S., & Piccart, M. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,180
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146

Show all 40 references

Sorted by citations

Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer
Kumar, V., Ramnarayanan, K., Sundar, R., Padmanabhan, N., Srivastava, S., Koiwa, M., Yasuda, T., Koh, V., Huang, K. K., Tay, S. T., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0683 · Cited by 573
Sublethal cytochrome c release generates drug-tolerant persister cells
Kalkavan, H., Chen, J., Crawford, J. C., Quarato, G., FITZGERALD, P. J., Tait, S. W. G., Goding, C. R., & Green, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.07.025 · Cited by 271
The Role of EREG/EGFR Pathway in Tumor Progression
Cheng, W., Feng, P., Lee, K., Chen, K.-Y., Sun, W.-L., Hiệp, N. V., Luo, C.-S., & Wu, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312828 · Cited by 246
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
Ma, S., Zhao, Y., Lee, W. C., Ong, L.-T., Lee, P. L., Jiang, Z., Oguz, G., Niu, Z., Liu, M., Goh, J. Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31764-9 · Cited by 200
Transient loss of Polycomb components induces an epigenetic cancer fate
Parreno, V., Loubière, V., Schuettengruber, B., Fritsch, L., Rawal, C. C., Erokhin, M., Győrffy, B., Normanno, D., Stefano, M. D., Moreaux, J., et al. (2024) · Nature · doi:10.1038/s41586-024-07328-w · Cited by 180
Self-citation
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
Maiani, E., Milletti, G., Nazio, F., Holdgaard, S. G., Bártková, J., Rizza, S., Cianfanelli, V., Lorente, M., Simoneschi, D., Marco, M. D., et al. (2021) · Nature · doi:10.1038/s41586-021-03422-5 · Cited by 153
Modeling Dense Multimodal Interactions Between Biological Pathways and Histology for Survival Prediction
Jaume, G., Vaidya, A. J., Chen, R. J., Williamson, D. F. K., Liang, P. P., & Mahmood, F. (2024) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr52733.2024.01100 · Cited by 184
A multi-omic single-cell landscape of human gynecologic malignancies
Regner, M. J., Wiśniewska, K., García‐Recio, S., Thennavan, A., Méndez-Giráldez, R., Malladi, V. S., Hawkins, G. M., Parker, J. S., Perou, C. M., Bae-Jump, V. L., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.013 · Cited by 144
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
Dai, Y.-Z., Liu, Y.-D., Li, J., Chen, M., Huang, M., Wang, F., Yang, Q., Yuan, J., & Sun, S. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00342-8 · Cited by 138
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
Fu, J., İmani, S., Wu, M.-Y., & Wu, R. (2023) · Cancers · doi:10.3390/cancers15194723 · Cited by 133
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
Huang, J., Tsang, W. Y., Fang, X., Zhang, Y., Luo, J., Gong, L., Zhang, B., Wong, C. N., Li, Z.-H., Liu, B., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-0966 · Cited by 113
SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition
Liu, L., Li, Y., Cao, D., Qiu, S., Li, Y., Jiang, C., Bian, R., Yang, Y., Li, L., Li, X., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.007 · Cited by 112
PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis
Fujita, H., Tanaka, Y., Ogata, S., Suzuki, N., Kuno, S., Barayeu, U., Akaike, T., Ogra, Y., & Iwaï, K. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01329-z · Cited by 109
A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers
Gu, Y., Tang, S., Wang, Z., Cai, L., Lian, H., Shen, Y., & Zhou, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1973220 · Cited by 99
The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients
Osipov, A., Nikolic, O., Gertych, A., Parker, S. J., Hendifar, A. E., Singh, P., Filippova, D., Dagliyan, G., Ferrone, C. R., Zheng, L., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00697-7 · Cited by 105
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions
MacFawn, I., Magnon, G. C., Gorecki, G., Kunning, S. R., Rashid, R., Ernest, M., Atiya, H. I., Ruffin, A. T., Taylor, S., Soong, T. R., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.007 · Cited by 98
Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors
Liu, Y., Wang, D., Li, Z., Li, X., Jin, M., Jia, N., Cui, X., Hu, G., Tang, T., & Yu, Q. (2022) · Scientific Reports · doi:10.1038/s41598-022-09889-0 · Cited by 96
A gene set enrichment analysis for cancer hallmarks
Menyhárt, O., Kothalawala, W. J., & Győrffy, B. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101065 · Cited by 92
Self-citation
Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis
Xie, C., Wang, F., Sang, Y., Chen, B., Huang, J.-H., He, F.-J., Li, H., Zhu, Y., Liu, X., Zhuang, S., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3910 · Cited by 87
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
Anuraga, G., Wang, W., Phan, N. N., Ton, N. T. A., Ta, H. D. K., Prayugo, F. B., Xuan, D. T. M., Ku, S., Wu, Y.-F., Andriani, V., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111089 · Cited by 87
Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench
Yang, Y., Chong, Y., Chen, M., Dai, W., Zhou, X., Ji, Y., Qiu, G., & Du, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02825-2 · Cited by 82
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
Mezheyeuski, A., Backman, M., Mattsson, J. S. M., Martín-Bernabé, A., Larsson, C., Hrynchyk, I., Hammarström, K., Ström, S., Ekström, J., Mauchanski, S., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104452 · Cited by 85
Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
Kim, S., Leem, G., Choi, J., Koh, Y., Lee, S., Nam, S., Kim, J. S., Park, C. H., Hwang, H. K., Min, K. I., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01287-7 · Cited by 81
Plectin in Cancer: From Biomarker to Therapeutic Target
Perez, S. M., Brinton, L. T., & Kelly, K. A. (2021) · Cells · doi:10.3390/cells10092246 · Cited by 77
Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis
Chen, D.-L., Cai, J.-H., & Wang, C. C. N. (2022) · Genes · doi:10.3390/genes13050902 · Cited by 73
DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients
Vasiyani, H., Mane, M., Rana, K., Shinde, A., Roy, M., Singh, J., Gohel, D., Currim, F., Srivastava, R., & Singh, R. K. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01763-8 · Cited by 72
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance
Scolaro, T., Manco, M., Pecqueux, M., Amorim, R., Trotta, R., Acker, H. H. V., Haele, M. V., Shirgaonkar, N., Naulaerts, S., Daniluk, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00771-8 · Cited by 77
Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma
Wang, P., Zhang, T., Wang, X., Xiao, H., Li, H., Zhou, L., Yang, T., Wei, B., Zhu, Z., Zhou, L., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.07.002 · Cited by 68
Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3
Le, T. T., Payne, S. L., Buckwald, M. N., Hayes, L. A., Parker, S. R., Burge, C. B., & Oudin, M. J. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00485-z · Cited by 70
Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity
Tang, Z.-H., Davidson, D., Li, R., Zhong, M., Qian, J., Chen, J., & Veillette, A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110111 · Cited by 63
An immunogenomic signature for molecular classification in hepatocellular carcinoma
Zhuang, W., Sun, H., Zhang, S., Zhou, Y., Weng, W., Wu, B., Ye, T., Huang, W., Lin, Z., Shi, L., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.06.024 · Cited by 61
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1
Kandasamy, P., Zlobec, I., Nydegger, D. T., Pujol‐Giménez, J., Bhardwaj, R., Shirasawa, S., Tsunoda, T., & Hediger, M. A. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12999 · Cited by 60
Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis
Dang, H.-H., Ta, H. D. K., Nguyen, T. T. T., Anuraga, G., Wang, C., Lee, K., & Le, N. Q. K. (2021) · Biomedicines · doi:10.3390/biomedicines9091144 · Cited by 60
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 + and CD8 + T‐cell protective responses to breast cancer
Mattiuz, R., Brousse, C., Ambrosini, M., Cancel, J.-C., Bessou, G., Mussard, J., Sanlaville, A., Caux, C., Bendriss‐Vermare, N., Valladeau‐Guilemond, J., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1305 · Cited by 61
Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer
Shi, Z., Tao, H., Fan, Z.-W., Song, S.-J., & Bai, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748925 · Cited by 57
Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma
Chen, W., Dong, K., Pan, X., Gan, S., Xu, D., Chen, J.-X., Chen, W., Li, W., Wang, Y., Wang, Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05566-w · Cited by 60
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth
Wolfe, A. L., Zhou, Q., Toska, E., Galeas, J., Ku, A. A., Koche, R. P., Bandyopadhyay, S., Scaltriti, M., Lebrilla, C. B., McCormick, F. P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103592118 · Cited by 55
OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor
Fan, C., Wang, Q., van der Zon, G., Ren, J., Agaser, C., Slieker, R. C., Iyengar, P. V., Mei, H., & ten Dijke, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00944-w · Cited by 55
5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling
Singh, D. K., Carcamo, S., Farias, E., Hasson, D., Zheng, W., Sun, D., Huang, X., Cheung, J. F., Nobre, A. R., Kale, N., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112560 · Cited by 54
The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
Chakraborty, G., Nandakumar, S., Hirani, R., Nguyen, B., Stopsack, K. H., Kreitzer, C. K., Rajanala, S. H., Ghale, R., Mazzu, Y. Z., Pillarsetty, N., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4272 · Cited by 54
Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
Mall, R., Bynigeri, R. R., Karki, R., Malireddi, R. K. S., Sharma, B. R., & Kanneganti, T. (2022) · NAR Cancer · doi:10.1093/narcan/zcac033 · Cited by 55
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
Yan, L., Zhang, Z., Liu, Y., Ren, S., Zhu, Z., Wei, L., Feng, J., Duan, T., Sun, X., Xie, T., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.862932 · Cited by 53
Aminopeptidase N‐Responsive Conjugates with Tunable Charge‐Reversal Properties for Highly Efficient Tumor Accumulation and Penetration
Sun, R., Zhang, Y., Lin, X., Piao, Y., Xie, T., He, Y., Xiang, J., Shao, S., Zhou, Q., Zhou, Z., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202217408 · Cited by 50
PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C
Xu, N., Ren, Y., Bao, Y., Shen, X., Kang, J., Wang, N., Wang, Z., Han, X., Li, Z., Zuo, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113041 · Cited by 50
Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer
Sun, H., Zhang, D., Huang, C., Guo, Y., Yang, Z., Yao, N., Dong, X., Cheng, R.-F., Zhao, N., Meng, J., et al. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0158 · Cited by 48
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma
Lu, J., Zhang, Y., Sun, M., Ding, C., Zhang, L., Kong, Y., Cai, M., Miccoli, P., Ma, C., & Yue, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737127 · Cited by 48
miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer
Wang, C., Li, X., Zhang, L., Chen, Y., Dong, R., Zhang, J., Zhao, J., Guo, X., Yang, G., Yan, L., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107822 · Cited by 47
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment
de la Calle‐Fabregat, C., Calafell-Segura, J., Gardet, M., Dunsmore, G., Mulder, K., Ciudad, L., Silvin, A., Moreno‐Càceres, J., Corbí, A. L., Muñoz‐Pinedo, C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq5226 · Cited by 48
E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer
Liu, Z., Liu, C., Fan, C., Li, R., Zhang, S., Liu, J., Li, B., Zhang, S., Guo, L., Wang, X., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101154 · Cited by 47
Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma
Wang, Y., Qiu, S., Wang, H., Cui, J., Tian, X., Miao, Y., Zhang, C., Cao, L., Ma, L., Xu, X., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719187 · Cited by 48
SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma
You, W., Ke, J., Chen, Y., Cai, Z., Huang, Z.-P., Hu, P., & Wu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864244 · Cited by 46
Comprehensive Integrative Analysis Reveals the Association of KLF4 with Macrophage Infiltration and Polarization in Lung Cancer Microenvironment
Arora, S., Singh, P. K., Ahmad, S., Ahmad, T., Dohare, R., Almatroodi, S. A., Alrumaihi, F., Rahmani, A. H., & Syed, M. A. (2021) · Cells · doi:10.3390/cells10082091 · Cited by 45
SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling
Zhang, W., Yang, S., Chen, D., Yuwen, D., Zhang, J., Wei, X., Han, X., & Guan, X. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04120-1 · Cited by 46
Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma
Guo, N. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2157 · Cited by 41
MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
Wu, S., Lin, K., Lawal, B., Wu, A. T. H., & Wu, C. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.047 · Cited by 43
TGF-β1 Potentiates Adoptive Immunotherapy of Hematological and Solid Tumors Using ex vivo Expanded γδ T-Cells
Beatson, R., Parente‐Pereira, A. C., Halim, L., Cozzetto, D., Hull, C., Whilding, L. M., Martínez, O., Taylor, C. A., Obajdin, J., Hoang, K. N. L., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100473 · Cited by 44
Self-citation
Combination Effect of Novel Bimetallic Ag-Ni Nanoparticles with Fluconazole against Candida albicans
Kamli, M. R., Alzahrani, E. A., Albukhari, S. M., Ahmad, A., Sabir, J. S. M., & Malik, M. A. (2022) · Journal of Fungi · doi:10.3390/jof8070733 · Cited by 43
p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP
Huang, Y., Chen, X., Wang, C., Deng, J., Zuo, Z., Wu, H., Xiong, J., Wu, X., Lu, H., Hao, Q., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113426 · Cited by 42
TGF-β generates a population of cancer cells residing in G1 phase with high motility and metastatic potential via KRTAP2-3
Takahashi, K., Podyma‐Inoue, K. A., Saito, M., Sakakitani, S., Sugauchi, A., Iida, K., Iwabuchi, S., Koinuma, D., Kurioka, K., Konishi, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111411 · Cited by 40
Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization
Pei, W., Wei, K., Wu, Y., Qiu, Q., Zhu, H., Mao, L., Shi, X., Zhang, S., Shi, Y., Tao, S., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147692 · Cited by 41
IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling
Zheng, C., Wang, J., Zhou, Y. L., Duan, Y., Zheng, R., Xie, Y., Wei, X., Wu, J., Shen, H., Ye, M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114088 · Cited by 40
A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer
Kelly, M. R., Wiśniewska, K., Regner, M. J., Lewis, M. W., Perreault, A. A., Davis, E. S., Phanstiel, D. H., Parker, J. S., & Franco, H. L. (2022) · Nature Communications · doi:10.1038/s41467-022-31919-8 · Cited by 42
Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
Cheng, X., Wang, J., Liu, C., Jiang, T., Yang, N., Liu, D., Zhao, H., & Xu, Z. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01999-3 · Cited by 42
Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer
Porciuncula, A., Morgado, M., Gupta, R., Syrigos, K., Meehan, R., Zacharek, S. J., Frederick, J. P., & Schalper, K. A. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0987 · Cited by 39
Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers
Wang, J., Liu, W., Li, J. C., Li, M., Li, B., & Zhu, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.714756 · Cited by 38
Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers
Peng, D., Wei, C., Zhang, X., Li, S., Liang, H., Zheng, X., Jiang, S., & Han, L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02266-3 · Cited by 38
Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis
Bhat, M., Pasini, E., Pastrello, C., Angeli, M., Baciu, C., Abovsky, M., Coffee, A., Adeyi, O. A., Kotlyar, M., & Jurišica, I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.777834 · Cited by 37
SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling
Zhou, Z., Zhang, Z., Chen, H., Bao, W., Kuang, X., Zhou, P., Gao, Z., Li, D., Xie, X., Yang, C., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01794-7 · Cited by 40
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
Hashemi, M., Hasani, S., Hajimazdarany, S., Mirmazloomi, S. R., Makvandy, S., Zabihi, A., Goldoost, Y., Gholinia, N., Kakavand, A., Tavakolpournegari, A., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.203 · Cited by 37
MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells
Sun, D., Singh, D. K., Carcamo, S., Filipescu, D., Khalil, B. D., Huang, X., Miles, B. A., Westra, W. H., Sproll, K. C., Hasson, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0876 · Cited by 37
TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content
Günalp, S., Helvaci, D. G., Oner, A., Bursalı, A., Conforte, A. J., Güner, H., Karakülah, G., Szegezdi, É., & Sağ, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1209249 · Cited by 38
A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma
Ye, Z., Zheng, M., Zeng, Y., Wei, S., Huang, H., Wang, Y., Liu, Q., Lin, Z., Chen, S., Zheng, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.612952 · Cited by 36
CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis
Ghosh, S., Ataman, M., Bąk, M., Börsch, A., Schmidt, A., Buczak, K., Martin, G., Dimitriades, B., Herrmann, C., Kanitz, A., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac114 · Cited by 37
Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression
Hou, T. Y., & Kraus, W. L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110944 · Cited by 40
Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?
Gao, X.-P., Dong, J., Xie, T., & Guan, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695544 · Cited by 35
Elevated MMP10/13 mediated barrier disruption and NF-κB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice
Tang, K., Wu, Z., Sun, M., Huang, X., Sun, J., Shi, J., Wang, X., Miao, Z., Gao, P., Song, Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.12.033 · Cited by 35
MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer
Yang, M., Xiao, R., Wang, X., Xiong, Y., Duan, Z., Li, D., & Kan, Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-97 · Cited by 35
RETRACTED: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
Zeng, J., Zhang, H., Tan, Y., Wang, Z., Li, Y., & Yang, X. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.06.005 · Cited by 34
Retracted
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
Lee, S. H., & Jang, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0394 · Cited by 39
SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment
Zhang, D., Lindstrom, A. R., Kim, E. J.-H., Hwang, C., Hall, M. L., Lin, T., & Li, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.890154 · Cited by 35
High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma
Zhang, Q., Xia, T., Qi, C., Du, J., & Ye, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-09180-5 · Cited by 34
cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines
Cheng, X., Liu, Y., Wang, J., Chen, Y., Robertson, A. G., Zhang, X., Jones, S. J. M., & Taubert, S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac090 · Cited by 36
Transmembrane protein TMEM119 facilitates the stemness of breast cancer cells by activating Wnt/β-catenin pathway
Yang, B., Wang, F., & Zheng, G. (2021) · Bioengineered · doi:10.1080/21655979.2021.1960464 · Cited by 33
Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer
Zhang, Z., Qiu, X., Yan, Y., Liang, Q., Cai, Y., Peng, B., Xu, Z., & Xia, F. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s329031 · Cited by 33
The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC
Wang, Z., Zhang, L., Xu, W., Li, J., Liu, Y., Zeng, X., Zhong, M., & Zhu, Y. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s341001 · Cited by 32
Long-read sequencing reveals oncogenic mechanism of HPV-human fusion transcripts in cervical cancer
Liu, M., Han, Z., Zhi, Y., Ruan, Y., Cao, G., Wang, G., Xu, X., Mu, J., Kang, J., Dai, F., et al. (2022) · Translational research · doi:10.1016/j.trsl.2022.09.004 · Cited by 32
Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer
Yu, S., Li, X., Zhang, J., & Wu, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.709493 · Cited by 31
TRPV2 Promotes Cell Migration and Invasion in Gastric Cancer via the Transforming Growth Factor-β Signaling Pathway
Kato, S., Shiozaki, A., Kudou, M., Shimizu, H., Kosuga, T., Ohashi, T., Arita, T., Konishi, H., Komatsu, S., Kubota, T., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-11132-5 · Cited by 31
Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma
Zhu, Z., Tang, N., Wang, M.-F., Zhou, J., Wang, J., Ren, H., & Shi, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.781087 · Cited by 31
miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling
Arora, S., Singh, P., Tabassum, G., Dohare, R., & Syed, M. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120722 · Cited by 32
METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma
Liu, B., Cao, J., Wu, B., Hao, K., Wang, X., Chen, X., & Shen, Z. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01148-7 · Cited by 30
Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
Graziano, V., Dannhorn, A., Hulme, H., Williamson, K., Buckley, H., Karim, S. A., Wilson, M., Lee, S. Y., Kaistha, B. P., Islam, S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006457 · Cited by 36
Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis
Yuan, C., Zhang, J., Lou, J., Wang, S., Jiang, Y., Wu, F., & Wang, S. (2021) · Bioengineered · doi:10.1080/21655979.2021.1951928 · Cited by 30
Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors
Belotti, Y., Tolomeo, S., Yu, R., Lim, W., & Lim, C. T. (2022) · Cancers · doi:10.3390/cancers14102544 · Cited by 31
A cancer-associated RNA polymerase III identity drives robust transcription and expression of snaR-A noncoding RNA
Bortle, K. V., Marciano, D. P., Liu, Q., Chou, T., Lipchik, A. M., Gollapudi, S., Geller, B. S., Monte, E., Kamakaka, R. T., & Snyder, M. P. (2022) · Nature Communications · doi:10.1038/s41467-022-30323-6 · Cited by 32
Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity
Tian, W., Zhou, J., Chen, M., Qiu, L., Li, Y., Zhang, W., Guo, R., Lei, N., & Chang, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-15866-4 · Cited by 30
Lower expression of NINJ1 (Ninjurin 1), a mediator of plasma membrane rupture, is associated with advanced disease and worse prognosis in serous ovarian cancer
Berkel, Ç., & Çaçan, E. (2022) · Immunologic Research · doi:10.1007/s12026-022-09323-7 · Cited by 31
μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial
Wang, X., Zhang, S., Jin, D., Luo, J., Shi, Y., Zhang, Y., Wu, L., Song, Y., Su, D., Pan, Z., et al. (2023) · 癌症：英文版 · doi:10.1002/cac2.12408 · Cited by 30
Musashi–1—A Stemness RBP for Cancer Therapy?
Bley, N., Hmedat, A., Müller, S., Rolnik, R. B., Rausch, A., Lederer, M., & Hüttelmaier, S. (2021) · Biology · doi:10.3390/biology10050407 · Cited by 29
E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer
Jusino, S., Rivera-Rivera, Y., Chardón-Colón, C., Ruiz-Justiz, A. J., Velázquez, J. J. V., Isidro, A., Cruz-Robles, M. E., Bonilla-Claudio, M., Armaiz-Peña, G. N., & Saavedra, H. I. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211035693 · Cited by 29

Authors: Nagy, Á., Munkácsy, G., & Győrffy, B.
Affiliations: Semmelweis University (HU)
Corresponding author: Győrffy, Balázs
ORCID: Nagy, Ádám
Munkácsy, Gyöngyi
Győrffy, Balázs
Venue: Scientific Reports
Publisher: Springer Science and Business Media LLC
Published: 2021-03-15
Volume: 11
Issue: 1
Pages: 6047-6047
ISSN: 2045-2322 (ISSN-L)
DOI: 10.1038/s41598-021-84787-5
PMC: PMC7961001
OpenAlex: W3139511935
Cited by: 1,381
References: 40
Citations by year: 2026: 38 · 2025: 84 · 2024: 145 · 2023: 504 · 2022: 311 · 2021: 298
FWCI: 101.01
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Scientific Reports (publishedVersion, cc-by)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Semmelweis Egyetem
Innovációs és Technológiai Minisztérium (ÚNKP-19-3, 2018-2.1.17-TET-KR-00001)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords: prognostic gene signature, survival analysis, genomic instability, invasion and metastasis, replicative immortality, cell death resistance, angiogenesis, tumor suppressor, BRCA1, RUNX1, SERPINE1, CDK1, E2F1, epiregulin, c-Myc, clear cell renal cell carcinoma, low-grade glioma, cervical cancer, bladder cancer, thyroid cancer, glioblastoma, tissue specificity, targeted therapy
MeSH terms: RNA-Seq, Humans, Neoplasms, Biomarkers, Tumor, Survival Rate, Disease-Free Survival, Databases, Nucleic Acid, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pancancer survival analysis of cancer hallmark genes

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks